Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor + G-CSF vs placebo + G-CSF for stem cell mobilization in NHL
CTR20161069Phase 2Completed
- Sponsor
- Sinopharm Yixin Pharmaceutical Co., Ltd.
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in non-Hodgkin lymphoma (NHL), sponsored by Sinopharm Yixin Pharmaceutical Co., Ltd.. Started Jan 2017; status: completed.
02
Drugs
plerixafor
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on CTR20161069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20161069.